Cell Therapy

Top Story

Outpatient treatment with lisocabtagene maraleucel feasible for certain patients with non-Hodgkin lymphoma

February 20, 2020

Read the Perspective from Mazyar Shadman, MD

In the Journals

CAR-T confers long-term quality-of-life improvement among patients with advanced lymphoma

February 19, 2020
Patients with relapsed or refractory diffuse large B-cell lymphoma experienced clinically meaningful improvements in long-term quality-of-life measurements after…
Trend Watch

St. Jude researcher receives grant to develop gene therapies for pediatric sarcoma

February 18, 2020
Alliance for Cancer Gene Therapy awarded a $500,000 grant to Stephen Gottschalk, MD, to develop gene therapies for pediatric sarcoma. Gottschalk, chair of the…
FDA News

FDA grants priority review to lisocabtagene maraleucel for advanced B-cell lymphoma

February 13, 2020
The FDA granted priority review to lisocabtagene maraleucel for the treatment of adults with relapsed or refractory large B-cell lymphoma, according to the agent’s…
More Headlines »